[ad_1]
Pharmaceutical company Boehringer Ingelheim has appointed Gagandeep Singh as Managing Director and Head of Human Pharma (India).
Singh will begin his new role from July 10 and will also join the Boehringer Ingelheim India board of directors, the company said.
Singh, the former head of AstraZeneca Pharma India, resigned in December last year.
Mr. Gagandeep Singh replaces Mr. Vani Mangya, who moved to Boehringer Ingelheim UK in February 2023. During the transition period, Sandip Agrawal, Director of Finance and Administration, has assumed additional responsibilities as Interim Managing Director.
-
Also read:A “healthy” return to our roots
Mohamed Tawil, Regional Managing Director and Head of Human Pharma (India, Middle East, Turkey and Africa) at Boehringer Ingelheim said: As countries face a significant burden of non-communicable diseases among young people, we recognize the growing need to address specific patient needs and healthcare challenges. ”
Mr. Gagandeep started his career in pharmaceutical sales and has 20 years of experience leading corporate strategy for multinational pharmaceutical companies in India and other emerging markets, the company added.
-
Also read: Global clinical trials revive, India gears up for more research
This is the last free article.
[ad_2]
Source link
